CommercialCoverageMedium impact
Multibiomarker Disease Activity Blood Test for Rheumatoid Arthritis
Blue Cross & Blue Shield of Mississippi·MS · Rheumatology·Medical Policy
We identified it
Jun 20, 2026
Summary
BCBS Mississippi has classified the Vectra multibiomarker disease activity blood test for rheumatoid arthritis as investigational in all situations, meaning it is not covered. This policy affects rheumatology practices that may have been billing for this specialized RA monitoring test.
Action Required
Immediately: Billing team must stop submitting claims for Vectra multibiomarker disease activity blood test for BCBS Mississippi members, as it is now classified as investigational and non-covered. Notify rheumatology providers that alternative RA disease activity measures should be used. Claims for this test will be denied.